Now showing items 1-20 of 434

      Title
      Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion [1]
      Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants [1]
      Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models [1]
      ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations [1]
      Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed. [1]
      Actively working to be more antiracist in the employee assistance field [1]
      Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data [1]
      Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations [1]
      Adapting clinical pharmacy staffing models during the COVID-19 pandemic: Lessons learned and considerations for future disaster planning [1]
      Addressing and Inspiring Vaccine Confidence in Black, Indigenous, and People of Color During the Coronavirus Disease 2019 Pandemic [1]
      Addressing challenges to rolling out COVID-19 vaccines in African countries [1]
      Addressing COVID-19 Vaccine Hesitancy in Patients with IBD [1]
      Adherence to personal protective equipment guidelines during the COVID-19 pandemic among healthcare personnel: A louisiana case study [1]
      Adjunctive nutraceutical therapies for COVID-19 [1]
      Advances in antiviral nucleoside analogues and their prodrugs [1]
      Aerosols Generated during Endodontic Treatment: A Special Concern during the Coronavirus Disease 2019 Pandemic [1]
      Airborne transmission of SARS-CoV-2 [1]
      Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID-19. [1]
      Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases [1]
      Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock [1]